2 weeks Ago By ABMN Staff
Prudential Financial Inc. increased its position in Globus Medical, Inc. ( NYSE:GMED – Free Report ) by 29.
6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 15,906 shares of the medical device company’s stock after purchasing an additional 3,637 shares during the period. Prudential Financial Inc.
’s holdings in Globus Medical were worth $1,316,000 at the end of the most recent quarter. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc.
grew its holdings in Globus Medical by 2.3% in the 4th quarter. Vanguard Group Inc.
now owns 10,863,834 shares of the medical device company’s stock worth $898,548,000 after acquiring an additional 240,218 shares during the last quarter. State Street Corp grew its stake in shares of Globus Medical by 2.3% in the third quarter.
State Street Corp now owns 3,570,726 shares of the medical device company’s stock worth $255,450,000 after purchasing an additional 81,371 shares during the last quarter. Geode Capital Management LLC increased its holdings in Globus Medical by 1.2% during the 3rd quarter.
Geode Capital Management LLC now owns 1,885,061 shares of the medical device company’s stock valued at $134,893,000 after purchasing an additional 21,935 shares during the period. Geneva Capital Management LLC raised its position in Globus Medical by 13.6% during the 4th quarter.
Geneva Capital Management LLC now owns 1,815,837 shares of the medical device company’s stock valued at $150,188,000 after purchasing an additional 217,707 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Globus Medical in the 4th quarter worth approximately $58,405,000.
95.16% of the stock is currently owned by institutional investors. Insider Activity In other news, CFO Keith W.
Pfeil sold 14,167 shares of the firm’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $88.29, for a total value of $1,250,804.
43. The transaction was disclosed in a filing with the SEC, which is available at the SEC website . Corporate insiders own 18.
54% of the company’s stock. Wall Street Analysts Forecast Growth Read Our Latest Research Report on GMED Globus Medical Stock Down 4.2 % Globus Medical stock opened at $69.
01 on Friday. Globus Medical, Inc. has a twelve month low of $49.
33 and a twelve month high of $94.93. The company has a market capitalization of $9.
49 billion, a P/E ratio of 92.01, a PEG ratio of 1.61 and a beta of 1.
19. The stock’s 50 day moving average is $80.17 and its 200 day moving average is $80.
03. Globus Medical ( NYSE:GMED – Get Free Report ) last released its earnings results on Thursday, February 20th. The medical device company reported $0.
84 EPS for the quarter, topping analysts’ consensus estimates of $0.74 by $0.10.
Globus Medical had a return on equity of 10.83% and a net margin of 4.09%.
The firm had revenue of $657.29 million for the quarter, compared to analysts’ expectations of $646.19 million.
As a group, equities analysts expect that Globus Medical, Inc. will post 3.44 EPS for the current year.
About Globus Medical ( Free Report ) Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. Read More Want to see what other hedge funds are holding GMED? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Globus Medical, Inc. ( NYSE:GMED – Free Report ). Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.
com's FREE daily email newsletter ..
